W. Kuehl

Molecular Biology · 2002–2009

A researcher in the Science corpus: 6 papers; trusts 1 researcher and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

Whom W. Kuehl trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. David M. Sabatini

Who trusts W. Kuehl overall

  1. S. Rajkumar
  2. T. Hideshima

Papers from W. Kuehl's perspective

Ordered by how strongly the researchers W. Kuehl trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma (Journal of Experimental Medicine)
  2. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. (Cell)
  3. mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt. (Cancer Research)
  4. Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma. (Blood)
  5. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling (Nature)
  6. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. (Molecules and Cells)
  7. Proteasome inhibitors disrupt the unfolded protein response in myeloma cells (Proceedings of the National Academy of Sciences of the United States of America)
  8. Constitutive Nuclear Factor κB Activity Is Required for Survival of Activated B Cell–like Diffuse Large B Cell Lymphoma Cells (Journal of Experimental Medicine)
  9. Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma. (Blood)
  10. PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. (Molecules and Cells)

Their papers